Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soteira was a medical device company that specialized in developing minimally invasive solutions for the treatment of vertebral compression fractures (VCF). The company's flagship product, the Shield Kyphoplasty System, utilized a unique balloon-like component designed to create a void in the vertebral body for the controlled and targeted delivery of bone cement. This technology aimed to restore vertebral height and alleviate pain in patients suffering from fractures caused by osteoporosis or cancer. In 2012, Soteira was acquired by Globus Medical for approximately $23.5 million, allowing Globus to expand its interventional spine and pain management portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soteira.